A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India

Clinical trial NCT07685769 · RECRUITING

Trial details

NCT number: NCT07685769
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Treatment of Migraine

Start date: 2026-07-24
Primary completion: 2028-01-04
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.